Back

Telomere shortening and cardiac alterations in asymptomatic type 2 diabetes patients: impact of sex

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Experiments in cardiac hypertrophy, atrophy, and remodelling Ventricular Remodelling ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Paul Balfanz

RWTH Aachen University, Aachen (Germany)

6 More presentations in this session

Presentation thumbnail
Titin hyper-phosphorylation in the peripheral skeletal muscle but not the diaphragm of HFpEF: association with muscle atrophy and dysfunction.
Mrs B. Vahle (Dresden, DE)
Abstract Slides Video
Presentation thumbnail
HECT domain containing-3 (HECTD3) E3 ubiquitin ligase attenuates cardiac ischemia and hypertrophy in mice
Doctor A. Deshpande (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Comparing the anti-remodeling effect of sacubitril/valsartan and angiotensin-converting enzyme inhibition on myocardial samples of advanced heart failure patients undergoing heart transplantation
Doctor D. Nagy (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Relationships between 18-month kinetics and functional capacity and left ventricular remodeling and cardiac fibrosis in dilated cardiomyopathy
Doctor S. Wisniowska-Smialek (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
The transcription factor foxo3 regulates cardiac remodeling after myocardial infarction
Professor C. Skurk (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Experiments in cardiac hypertrophy, atrophy, and remodelling

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Type 2 diabetes individuals have a shorter QRS duration, prolonged QTc interval, flatter T wave, and reduced left ventricular cycle volumes compared to matched controls in the UK Biobank
thumbnail
Congress Presentation
Association of telomeres length with cardiovascular risk factors and arterial stiffness
thumbnail
Congress Presentation
Gender differences in cardiac transthyretin amyloidosis: diagnostic gap in female patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources